drugset / Trial / NCT04884997
A Study of Toripalimab or Combining With Temozolomide（iv） in the Treatment of Advanced/Metastatic Malignant Melanoma
RandomizedParallel-groupOpen-labelTreatment
Summary
This study evaluate toripalimab or combining with temozolomide for injection in the treatment of advanced/metastatic malignant melanoma. Participants in arm A receive toripalimab, in arm B receive toripalimab plus temozolomide
Timeline
- Start
- 2021-03-07
- Primary completion
- 2024-03-07
- Completion
- 2024-09-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Temozolomide | Small molecule | 150 mg/m2 | — |
| Subject | Toripalimab | Monoclonal antibody | 3 mg/kg | — |